cinnarizine structure 
             | 
        Common Name | cinnarizine | ||
|---|---|---|---|---|
| CAS Number | 298-57-7 | Molecular Weight | 368.514 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 509.2±38.0 °C at 760 mmHg | |
| Molecular Formula | C26H28N2 | Melting Point | 117-120ºC | |
| MSDS | Chinese USA | Flash Point | 229.8±14.6 °C | |
            Use of cinnarizineCinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.  | 
    
| Name | cinnarizine | 
|---|---|
| Synonym | More Synonyms | 
| Description | Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. | 
|---|---|
| Related Catalog | 
| Density | 1.1±0.1 g/cm3 | 
|---|---|
| Boiling Point | 509.2±38.0 °C at 760 mmHg | 
| Melting Point | 117-120ºC | 
| Molecular Formula | C26H28N2 | 
| Molecular Weight | 368.514 | 
| Flash Point | 229.8±14.6 °C | 
| Exact Mass | 368.225250 | 
| PSA | 6.48000 | 
| LogP | 4.63 | 
| Vapour Pressure | 0.0±1.3 mmHg at 25°C | 
| Index of Refraction | 1.626 | 
| Storage condition | Refrigerator | 
                                    CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  | 
                            
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter | 
|---|---|
| Hazard Codes | Xn | 
| Risk Phrases | R20/22 | 
| Safety Phrases | S22-S24/25 | 
| RIDADR | NONH for all modes of transport | 
| WGK Germany | 2 | 
| RTECS | TL3430000 | 
| HS Code | 2933599090 | 
| 
                                        
                                        
                                        
                                        
                                         ~79%  
                                            cinnarizine CAS#:298-57-7  | 
                                
| Literature: RSC Advances, , vol. 3, # 43 p. 20708 - 20718 | 
| 
                                        
                                        
                                        
                                        
                                         ~75%  
                                            cinnarizine CAS#:298-57-7  | 
                                
| Literature: Journal of the American Chemical Society, , vol. 134, # 51 p. 20613 - 20616 | 
| HS Code | 2933599090 | 
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% | 
| 
                                    
                                    Iron oxide induced enhancement of mucoadhesive potential of Eudragit RLPO: formulation, evaluation and optimization of mucoadhesive drug delivery system.
                                    
                                    
                                     Expert Opin. Drug Deliv. 10(9) , 1179-91, (2013) The objective of the study was to investigate the effect of iron oxide in the development of mucoadhesive tablets of cinnarizine using Eudragit RLPO polymer. A simplex lattice design was employed for ...  | 
                                |
| 
                                    
                                    A combination turbidity and supernatant microplate assay to rank-order the supersaturation limits of early drug candidates.
                                    
                                    
                                     J. Pharm. Sci. 103(10) , 3022-32, (2014) A unique opportunity exists at the drug discovery stage to overcome inherently poor solubility by selecting drug candidates with superior supersaturation propensity. Existing supersaturation assays co...  | 
                                |
| 
                                    
                                    Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.
                                    
                                    
                                     J. Phys. Chem. B 118(33) , 9974-82, (2014) Amorphous forms of drugs are increasingly being used to deliver poorly water-soluble compounds. Therefore, understanding the magnitude and origin of differences in crystallization kinetics is highly i...  | 
                                
| 1-Diphenylmethyl-4-trans-cinnamylpiperazine | 
| stugeron | 
| 1-trans-Cinnamyl-4-diphenylmethylpiperazine | 
| Denapol | 
| 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine | 
| Siptazin | 
| Artate | 
| Carecin | 
| Piperazine, 1-(diphenylmethyl)-4-[(2E)-3-phenyl-2-propen-1-yl]- | 
| Processine | 
| piperazine, 1-(diphenylmethyl)-4-[(2E)-3-phenyl-2-propenyl]- | 
| Apotomin | 
| Mitronal | 
| Piperazine, 1-cinnamyl-4- (diphenylmethyl)-, (E)- | 
| Glanil | 
| Stutgin | 
| Aplactan | 
| Labyrin | 
| N-Benzhydryl-N'-trans-cinnamylpiperazine | 
| 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine | 
| Cinnacet | 
| Toliman | 
| Cinazyn | 
| Midronal | 
| Sedatromin | 
| Olamin | 
| Cinnageron | 
| Katoseran | 
| Giganten | 
| Ixertol | 
| cinnarizine | 
| Cinnipirine | 
| Hilactan | 
| EINECS 206-064-8 | 
| Corathiem | 
| Spaderizine | 
| 1-Cinnamyl-4-benzhydrylpiperazine | 
| Stutgeron | 
| Aplexal | 
| Cerebolan | 
| Eglen | 
| 1-(Diphenylmethyl)-4-[(2E)-3-phenyl-2-propen-1-yl]piperazine | 
| MFCD00056037 | 
| Folcodal | 
| Cinaperazine | 
| Piperazine, 1- (diphenylmethyl)-4-(3-phenyl-2-propenyl)-, (E)- | 
| UNII-3DI2E1X18L |